The Role of Local Angiotensin II/Angiotensin Type 1-receptor Mechanisms in Adipose Tissue Dysfunction to Promote Pancreatic Cancer
- PMID: 38347780
- DOI: 10.2174/0115680096281059240103154836
The Role of Local Angiotensin II/Angiotensin Type 1-receptor Mechanisms in Adipose Tissue Dysfunction to Promote Pancreatic Cancer
Abstract
Obesity and adipose tissue dysfunction are important risk factors for pancreatic cancer. Pancreatic cancer is one of the most lethal cancers globally. The renin-angiotensin system (RAS) is expressed in many tissues, including adipose tissue. Dysregulation of angiotensin II and angiotensin II receptors in adipose tissue through the activation of different signaling pathways leads to adipose tissue dysfunction, including insulin resistance, adipose tissue inflammation, adipocytokines secretion, and metabolic alterations. The pathogenesis of pancreatic cancer remains uncertain. However, there is evidence that dysregulation of local angiotensin II in adipose tissue that occurs in association with obesity is, in part, responsible for the initiation and progression of pancreatic cancer. Due to the role of local angiotensin II in the dysfunction of adipose tissue, angiotensin receptor blockers may be considered a new therapeutic strategy in the amelioration of the complications related to adipose tissue dysfunction and prevention of pancreatic cancer. This review aims to consider the biological roles of local angiotensin II and angiotensin II receptors in adipose tissue dysfunction to promote pancreatic cancer progression with a focus on adipose tissue inflammation and metabolic reprogramming.
Keywords: Adipose tissue; angiotensin II; angiotensin receptor; angiotensin receptor.; obesity; pancreatic cancer.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity.Endocr Regul. 2016 Oct 1;50(4):229-240. doi: 10.1515/enr-2016-0025. Endocr Regul. 2016. PMID: 27941178 Review.
-
Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.Mol Cell Endocrinol. 2013 Sep 25;378(1-2):23-8. doi: 10.1016/j.mce.2012.03.005. Epub 2012 Mar 23. Mol Cell Endocrinol. 2013. PMID: 22465098 Review.
-
The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.J Nutr Biochem. 2013 Dec;24(12):2003-15. doi: 10.1016/j.jnutbio.2013.07.002. Epub 2013 Oct 9. J Nutr Biochem. 2013. PMID: 24120291 Review.
-
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.Obes Rev. 2003 Feb;4(1):43-55. doi: 10.1046/j.1467-789x.2003.00091.x. Obes Rev. 2003. PMID: 12608526 Review.
-
Role of the RAS in pancreatic cancer.Curr Cancer Drug Targets. 2011 May;11(4):412-20. doi: 10.2174/156800911795538110. Curr Cancer Drug Targets. 2011. PMID: 21395550 Review.
References
-
- El Sebaey R.S.; Assessment of possible role of renin angiotensin aldosterone system in obesity. Egypt J Hosp Med 2023,91(1),4828-4831 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical